Autologous Stem Cells

BIOLOGICAL10 trials

Conditions

Acute Myocardial InfarctionCardiovascular DiseaseChronic Low Back PainCongestive Heart FailureCoronary Artery DiseaseDegenerative Disc DiseaseDevic's DiseaseMultiple Myeloma

Early Phase 1

Comparative split face study for the efficacy and safety of micro-needling alone versus micro-needling combined with botulinum toxin-A or autologous stem cells or irradiated amniotic collagen matrix in the treatment of atrophic acne scars

Active, not recruitingPACTR202508850407266

tanta universtySkin and Connective Tissue Diseases

Start: 2024-01-01Target: 60Updated: 2026-01-27

Phase 1

Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus

CompletedNCT01786707

Rodolfo AlejandroType 2 Diabetes Mellitus

Start: 2009-07-31End: 2013-03-31Updated: 2017-07-02

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

CompletedNCT02038972

James Baumgartner, MDSensorineural Hearing Loss

Start: 2013-01-31End: 2017-01-10Updated: 2018-03-05

Phase 2

Stem Cell Study for Patients With Heart Failure

WithdrawnNCT00346177

Losordo, Douglas, M.D.Cardiovascular Disease, Congestive Heart Failure, Myocardial Ischemia

Start: 2010-09-30End: 2012-09-30Target: 30Updated: 2010-09-14

Intracoronary Stem Cell Therapy in Patients With Acute Myocardial Infarction (SCAMI)

CompletedNCT00669227

University of UlmAcute Myocardial Infarction, Coronary Artery Disease

Start: 2005-10-31Updated: 2014-06-10

Cardiac Safe Transplants for Systemic Sclerosis

TerminatedNCT03593902

Northwestern UniversityScleroderma, Systemic Sclerosis

Start: 2018-05-17End: 2019-10-09Updated: 2020-08-12

Autologous Transplant To End NMO Spectrum Disorder

WithdrawnNCT03829566

Northwestern UniversityDevic's Disease, Neuromyelitis Optica, NMO Spectrum Disorder

Start: 2019-11-30End: 2025-11-28Updated: 2019-11-20

Phase 3

Maximizing Outcome of Multiple Sclerosis Transplantation

TerminatedNCT03342638

Northwestern UniversityMultiple Sclerosis, Relapsing-Remitting

Start: 2017-11-08End: 2019-10-09Updated: 2021-01-11

Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

TerminatedNCT05675319

Universitätsklinikum Hamburg-EppendorfMultiple Myeloma

Start: 2023-03-03End: 2025-03-21Updated: 2026-01-05

Unknown Phase

Stem Cells vs. Steroids for Discogenic Back Pain

WithdrawnNCT04735185

Johns Hopkins UniversityChronic Low Back Pain, Degenerative Disc Disease

Start: 2025-09-30End: 2028-11-30Updated: 2025-10-07

Related Papers

Rationale and design of the multicenter, national, randomized, open labeled phase III trial: allogeneic stem cell transplantation as a potential curative treatment for patients with relapsed or progressed multiple myeloma (AlloRelapseMM Study).

2025-01-271 citations

Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party

Haematologica2020-01-16106 citations